iifl-logo

Remus Pharmaceuticals Ltd Share Price Live

₹840.85
(-4.77%)
Sep 5, 2025|12:00:00 AM

Invest wise with Expert advice

By continuing, I accept the T&C and agree to receive communication on Whatsapp

Equities

Futures

Option

  • Open₹886
  • Day's High₹886
  • 52 Wk High₹1,416.45
  • Prev. Close₹883
  • Day's Low₹833.5
  • 52 Wk Low ₹819
  • Turnover (lac)73.99
  • P/E52.28
  • Face Value₹10
  • Book Value₹0
  • EPS16.89
  • Mkt. Cap (Cr.)₹990.86
  • Div. Yield0
View All Historical Data

No Record Found

Loading...

Remus Pharmaceuticals Ltd KEY RATIOS

Sector

Pharmaceuticals

Open

₹886

Prev. Close

₹883

Turnover(Lac.)

₹73.99

Day's High

₹886

Day's Low

₹833.5

52 Week's High

₹1,416.45

52 Week's Low

₹819

Book Value

₹0

Face Value

₹10

Mkt Cap (₹ Cr.)

990.86

P/E

52.28

EPS

16.89

Divi. Yield

0

Remus Pharmaceuticals Ltd Corporate Action

29 Aug 2025

12:00 AM

Board Meeting

Agenda : Audited Result

arrow

29 Aug 2024

12:00 AM

AGM

Announcement Date: 29 Aug, 2024

arrow

Remus Pharmaceuticals Ltd NEWS AND UPDATE

No Record Found

Invest wise with Expert advice

By continuing, I accept the T&C and agree to receive communication on Whatsapp

Knowledge Center

Demat Account

View More

Trading Account

View More

Remus Pharmaceuticals Ltd SHAREHOLDING SNAPSHOT

05 Sep, 2025|11:17 PM
Jul-2025Mar-2025Sep-2024Jun-2024
  • Foreign Promoter
  • Indian Promoter
  • Institutions
  • Non Institutions
  • Custodies

Promoter- 70.85%

Foreign: 0.00%

Indian: 70.85%

Non-Promoter- 5.82%

Institutions: 5.82%

Non-Institutions: 23.32%

Custodian: 0.00%

Read More
Share Price

Remus Pharmaceuticals Ltd FINANCIALS

Balance Sheet

Profit & Loss

Cash Flow

Ratios

Results

Y/e 31 Mar( In .Cr)Mar-2024Mar-2023Mar-2022Mar-2021

Equity Capital

1.47

1.09

1

0.01

Preference Capital

0

0

0

0

Reserves

80.59

18.05

5.58

3.13

Net Worth

82.06

19.14

6.58

3.14

Minority Interest

View Balance Sheet

No Record Found

No Record Found

No Record Found

Particulars (Rupees in Crores.)Mar-2025Mar-2024

Gross Sales

620.36

212.94

Excise Duty

0

0

Net Sales

620.36

212.94

Other Operating Income

0

0

Other Income

4.98

2.83

Remus Pharmaceuticals Ltd Peer Comparison

Company Name
LTP
(₹)
P/E
(%)
Mkt.Cap
(₹Cr.)
NP Qtr
(₹Cr.)
Div.Yield
(%)
Sales Qtr
(₹.Cr)
Book Value
(₹)

Sun Pharmaceutical Industries Ltd

SUNPHARMA

1,582.3

76.223,79,658.77753.531.015,566.68101.44

Divis Laboratories Ltd

DIVISLAB

6,133.5

69.731,62,886.215570.492,357561.08

Cipla Ltd

CIPLA

1,577.8

24.671,27,435.321,303.131.014,501.66397.38

Torrent Pharmaceuticals Ltd

TORNTPHARM

3,599.3

61.231,21,713.055510.172,567224.34

Mankind Pharma Ltd

MANKIND

2,568.9

58.531,05,917.96412.7602,541.36354.69

Figures of Market Capital(Mar Cap), Quarterly Net Profit(NP Qtr) and Quarterly Sales(Sales Qtr) are in ₹ Cr.

View All Peer Comparision

MORE ABOUT Remus Pharmaceuticals Ltd

Management

Register Office

Registrar Office

No Record Found

Registered Office

1101 to 1103 South Tower One42,

B/H Ashok Vatika Amblibopal Rd,

Gujarat - 380054

Tel: 91-079-29999857

Website: https://www.remuspharma.com

Email: cs@remuspharma.com

Registrar Office

C-101 247 Park,

L B S Marg, Vikhroli West,

Mumbai-400083

Tel: 91-22-49186000

Website: www.linkintime.co.in

Email: paytm.ipo@linkintime.co.in

Summary

Remus Pharmaceuticals Limited was originally incorporated as Remus Pharmaceuticals Private Limited as a Private Limited Company, vide Certificate of Incorporation dated September 21, 2015, issued by t...
Read More

Reports by Remus Pharmaceuticals Ltd

Company FAQs

What is the Remus Pharmaceuticals Ltd share price today?

The Remus Pharmaceuticals Ltd shares price on NATIONAL STOCK EXCHANGE (NSE) is ₹840.85 today.

What is the Market Cap of Remus Pharmaceuticals Ltd?

Market capitalization, short for market cap, is the market value of a publicly traded company's outstanding shares. The market cap of Remus Pharmaceuticals Ltd is ₹990.86 Cr. as of 05 Sep ‘25

What is the PE and PB ratio of Remus Pharmaceuticals Ltd?

The PE and PB ratios of Remus Pharmaceuticals Ltd is 52.28 and 4.30 as of 05 Sep ‘25

What is the 52 Week High and Low of Remus Pharmaceuticals Ltd?

The 52-week high/low is the highest and lowest price at which a Remus Pharmaceuticals Ltd stock has traded during that given time period (similar to 1 year) and is considered as a technical indicator. The 52 week high and low of Remus Pharmaceuticals Ltd is ₹819 and ₹1416.45 as of 05 Sep ‘25

What is the CAGR of Remus Pharmaceuticals Ltd?

Remus Pharmaceuticals Ltd's CAGR for 5 Years at N/I%, 3 Years at 57.83%, 1 Year at -33.19%, 6 Month at -7.22%, 3 Month at -11.34% and 1 Month at -1.88%.

What is the shareholding pattern of Remus Pharmaceuticals Ltd?

The shareholding pattern of Remus Pharmaceuticals Ltd is as follows:
Promoters - 70.85 %
Institutions - 5.82 %
Public - 23.32 %

QUICKLINKS FOR Remus Pharmaceuticals Ltd

Information
Share PriceFutures PriceOption ChainHistorical Data
Financials
Profit & LossBalance SheetCash FlowKey Ratios
Results
Quarterly ResultHalf Yearly ResultNine Monthly ResultAnnual Result
News
Company
Market
Derivatives
IPO
Mutual Funds
Calculators
Nifty 50
Company
Knowledge Center
News
Logo

Logo IIFL Customer Care Number
(Gold/NCD/NBFC/Insurance/NPS)
1860-267-3000 / 7039-050-000

Logo IIFL Capital Services Support WhatsApp Number
+91 9892691696

Download The App Now

appapp
Loading...

Follow us on

facebooktwitterrssyoutubeinstagramlinkedintelegram

2025, IIFL Capital Services Ltd. All Rights Reserved

About
IIFL Group
Products & Services
Trading Documentation
Useful Links
For Investors

ATTENTION INVESTORS

RISK DISCLOSURE ON DERIVATIVES

Copyright © IIFL Capital Services Limited (Formerly known as IIFL Securities Ltd). All rights Reserved.

IIFL Capital Services Limited - Stock Broker SEBI Regn. No: INZ000164132, PMS SEBI Regn. No: INP000002213,IA SEBI Regn. No: INA000000623, SEBI RA Regn. No: INH000000248, DP SEBI Reg. No. IN-DP-185-2016, BSE Enlistment Number (RA): 5016
ARN NO : 47791 (AMFI Registered Mutual Fund Distributor)

ISO certification icon
We are ISO 27001:2013 Certified.

This Certificate Demonstrates That IIFL As An Organization Has Defined And Put In Place Best-Practice Information Security Processes.